Spark Holland B.V.and Axel Semrau have announced an expansion of their existing distribution deal to include Switzerland and Austria.
Spark Holland B.V. (Emmen, The Netherlands) and Axel Semrau (Sprockhövel, Germany) have announced an expansion of their existing distribution deal to include Switzerland and Austria. A deal had previously existed between the two companies for five years concerning the distribution of services within Germany.
“We are very pleased to extend the region in which Axel Semrau is our partner. In Germany its team is highly experienced in Spark Holland products. This helps our customers make the right choices in their sample prep challenges,” said Spark President, Rob van der Knaap.
The closer proximity of Axel Samrau to Switzerland and Austria was cited as a major positive in the deal, with improved support and maintenance programmes expected alongside market expansion.
“We can now increase the momentum of Spark’s wellârecognized and market-accepted on-line SPE technology to Swiss and Austrian customers,” said Axel Semrau’s CEO, Dr. Andreas Bruchmann.
For further information, please visit www.sparkholland.com and www.axel-semrau.com
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.